Director
DIN: 07879548
Abhishek Chandel is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Nominee. They serve as a Director at GOMEDII TECHNOLOGIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07879548.Abhishek Chandel is currently involved in 3 different roles. Their most recent position is with THREE 60 GLOBAL CARE FOUNDATION as a Director. The first company Abhishek Chandel was appointed to as a director was GOMEDII TECHNOLOGIES PRIVATE LIMITED. Abhishek Chandel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Abhishek Chandel is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Nominee. They serve as a Director at GOMEDII TECHNOLOGIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07879548.Abhishek Chandel is currently involved in 3 different roles. Their most recent position is with THREE 60 GLOBAL CARE FOUNDATION as a Director. The first company Abhishek Chandel was appointed to as a director was GOMEDII TECHNOLOGIES PRIVATE LIMITED. Abhishek Chandel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
1y 10m 11 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| GOMEDII TECHNOLOGIES PRIVATE LIMITED | Director | 31-Jul-2017 |
| GOMEDII TECHNOLOGIES PRIVATE LIMITED | Individual Promoter | 31-Jul-2017 |
| SHREEMSOFT TECHNOLOGIES (OPC) PRIVATE LIMITED | Nominee | 13-Apr-2023 |
| THREE 60 GLOBAL CARE FOUNDATION | Director | 30-Apr-2024 |